Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% |
|
+0.14% | +29.68% |
2023 | Nestle Reportedly May Sell Peanut Allergy Therapy to Stallergenes | CI |
2023 | Stallergenes Greer Ltd Initiates European Paediatric Phase III Study with Staloral Birch | CI |
1st Jan change | Capi. | |
---|---|---|
+29.68% | 0 | |
+15.86% | 894.91Cr | |
-24.00% | 431.05Cr | |
+13.37% | 421Cr | |
+31.17% | 410.48Cr | |
+6.41% | 220.57Cr | |
-34.04% | 196.02Cr | |
+7.56% | 194.75Cr | |
-0.50% | 164.41Cr | |
-47.93% | 161.5Cr |
- Stock Market
- Equities
- STAGR Stock
- News Stallergenes Greer
- Transcript : Stallergenes Greer Plc, H1 2018 Earnings Call, Aug 30, 2018